NADOFARAGENE FIRADENOVEC
UNII 0OOS09O1FH

Substance Identification & Data

This profile provides standardized clinical and technical data for Nadofaragene Firadenovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0OOS09O1FH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1823059-12-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0OOS09O1FH

CAS Registry Number

1823059-12-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NADOFARAGENE FIRADENOVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

0OOS09O1FH

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C71011

National Cancer Institute reference terminology for clinical and research data.

INN ID

10654

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-117

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nadofaragene Firadenovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NADOFARAGENE FIRADENOVEC

NADOFARAGENE FIRADENOVEC-VNCG

Common Names & Synonyms

NADOFARAGENE FIRADENOVEC [INN]

NADOFARAGENE FIRADENOVEC [USAN]

NADOFARAGENE FIRADENOVEC [WHO-DD]

NADOFARAGENE FIRADENOVEC VNCG [WHO-DD]

REPLICATION-DEFICIENT ADENOVIRUS TYPE 5 (AD5) VECTOR ENCODING THE HUMAN INTERFERON ALPHA 2 (IFNA2, INTERFERON ALPHA-2B) GENE UNDER THE CONTROL OF THE CYTOMEGALOVIRUS (CMV) IMMEDIATE-EARLY ENHANCER/PROMOTER